Yoshiiku Kawakami - Concepedia

Author

Yoshiiku Kawakami

Also Known As

Hiroiku Kawakami, Hiroto Katoh, Hitoshi Katai, Karin S. Kassahn, Mamoru Kato, Yoshi-iku Kawakami, Yoshiiku KAWAKAMI, Yoshiiku Kawakami, Yuko Nagaoki

225

Publications

21K

Citations

H-Index

Concepts

All Affiliations

Hiroshima University RIKEN Center for Integrative Medical Sciences Hiroshima University Hospital Life Science Institute The University of Tokyo

About

Yoshiiku Kawakami is an author at Hiroshima University specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	39	3.7K
2	Health Sciences	5	5	384
3	Public Health	2	2	96
4	Engineering	1	1	19
5	Natural Sciences	1	1	55

Yoshiiku Kawakami

109

Publications

11.3K

Citations

H-Index

Page 1

	Year	Citations
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators Akihiro Fujimoto, Yasushi Totoki, Tetsuo Abe, Nature Genetics ChromatinSomatic VariantChromatin RemodelingTumor HeterogeneityGenetics	2012	868
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer Akihiro Fujimoto, Mayuko Furuta, Yasushi Totoki, Nature Genetics Whole-genome Mutational LandscapeSomatic VariantTumor HeterogeneityMedicineGenetics	2016	703
Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection Hiromitsu Kumada, Yoshiyuki Suzuki, Kenji Ikeda, Hepatology	2014	538
Comprehensive molecular characterization of mitochondrial genomes in human cancers Yuan Yuan, Young Seok Ju, Young-Wook Kim, Nature Genetics	2020	489
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations Christopher P. Wardell, Masashi Fujita, Tōru Yamada, Journal of Hepatology	2018	361
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options Yoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki, Journal of Hepatology Limited Treatment OptionsViral HepatitisHcv Genotype 1BAntiviral Drug DevelopmentAntiviral Therapy	2012	235
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity Akihiro Fujimoto, Mayuko Furuta, Yuichi Shiraishi, Nature Communications	2015	230
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns Wei Jiao, Gurnit Atwal, Paz Polak, Nature Communications	2020	230
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors Arnoud Boot, Mi Ni Huang, Alvin Wei Tian Ng, Genome Research Cisplatin Mutational SignaturePathologyTumor BiologyOncologyTumor Heterogeneity	2018	187

Page 1